Want to see BGMS full AI Analyst Report?
Total Valuation
Bio Green Med Solution has a market cap or net worth of $5.85M. The enterprise value is -$1.55M.
Market Cap$5.85M
Enterprise Value-$1.55M
Share Statistics
Bio Green Med Solution has 5,519,456 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,519,456
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bio Green Med Solution’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -122.97%.
Return on Equity (ROE)-0.44
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-122.97%
Return on Capital Employed (ROCE)-1.23
Revenue Per Employee62.25K
Profits Per Employee-249.83K
Employee Count12
Asset Turnover0.09
Inventory Turnover0.44
Valuation Ratios
The current PE Ratio of Bio Green Med Solution is ―. Bio Green Med Solution’s PEG ratio is 0.00232.
PE Ratio―
PS Ratio4.33
PB Ratio0.47
Price to Fair Value0.47
Price to FCF-0.68
Price to Operating Cash Flow-3.21
PEG Ratio0.00232
Income Statement
In the last 12 months, Bio Green Med Solution had revenue of 747.00K and earned -3.00M in profits. Earnings per share was -6.45.
Revenue747.00K
Gross Profit138.00K
Operating Income-8.43M
Pretax Income-2.99M
Net Income-3.00M
EBITDA-8.42M
Earnings Per Share (EPS)-6.45
Cash Flow
In the last 12 months, operating cash flow was -1.80M and capital expenditures -1.00K, giving a free cash flow of -1.80M billion.
Operating Cash Flow-1.80M
Free Cash Flow-1.80M
Free Cash Flow per Share-0.33
Dividends & Yields
Bio Green Med Solution pays an annual dividend of $0.15, resulting in a dividend yield of 10.27%
Dividend Per Share$0.15
Dividend Yield10.27%
Payout Ratio-6.55%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.57
52-Week Price Change-70.06%
50-Day Moving Average0.94
200-Day Moving Average1.64
Relative Strength Index (RSI)58.93
Average Volume (3m)473.94K
Important Dates
Bio Green Med Solution upcoming earnings date is Aug 12, 2026, TBA (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
Bio Green Med Solution as a current ratio of 4.70, with Debt / Equity ratio of 0.00%
Current Ratio4.70
Quick Ratio3.66
Debt to Market Cap0.00
Net Debt to EBITDA0.42
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Bio Green Med Solution has paid 7.00K in taxes.
Income Tax7.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Bio Green Med Solution EV to EBITDA ratio is 0.03, with an EV/FCF ratio of 0.06.
EV to Sales-0.36
EV to EBITDA0.03
EV to Free Cash Flow0.06
EV to Operating Cash Flow0.06
Balance Sheet
Bio Green Med Solution has $3.34M in cash and marketable securities with $0.00 in debt, giving a net cash position of $3.34M billion.
Cash & Marketable Securities$3.34M
Total Debt$0.00
Net Cash$3.34M
Net Cash Per Share$0.60
Tangible Book Value Per Share$2.41
Margins
Gross margin is 18.36%, with operating margin of -1128.11%, and net profit margin of -401.34%.
Gross Margin18.36%
Operating Margin-1128.11%
Pretax Margin-400.40%
Net Profit Margin-401.34%
EBITDA Margin-1127.44%
EBIT Margin-1128.11%
Analyst Forecast
The average price target for Bio Green Med Solution is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast10792.86%
EPS Growth Forecast99.40%